Drug Approval | May 27, 2023
Eugia Pharma receives USFDA approval for Carboprost Tromethamine Injection
The product is expected to be launched in June 2023
The product is expected to be launched in June 2023
For Q4 ended FY23, company reported net profit of Rs. 12.56 crore as against net profit of Rs. 11.02 crore in the corresponding period last year
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Ephedrine Sulfate Injection USP, 50 mg/mL had annual sales of USD 52 mn in the United States
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of USD 1.9 mn in the United States
Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Subscribe To Our Newsletter & Stay Updated
